Toll-like receptor-mediated inflammatory disease therapy - Pfizer, Opsona
Abrysvo (PF-06928316) - Pfizer
mRESVIA (respiratory syncytial virus vaccine) - Moderna
Arexvy (respiratory syncytial virus vaccine, adjuvanted) - GSK
http://www.ncbi.nlm.nih.gov/pubmed/40226615
 
Afaque A Momin; Bandar Alosaimi; Fahad M Aldakheel; Hadeel Alnajran; Intikhab Alam; Maaweya Awadalla; Wael Alturaiki
 
Apr 14, 2025
 
Next